Genentech at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Genentech brings 3 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 125. The Roche Group company's posters look at its oral SERD giredestrant: how tumors respond and resist, thymidine kinase activity in combinations and the societal impact of adjuvant use in HR-positive disease.
| Organization | SABCS 2026 Attendance |
|---|---|
Genentech South San Francisco, CA | |
Roche Group biotechnology company whose breast cancer medicines include HER2-targeted antibodies and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 125 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 12:30–2pm Talk Thu Dec 10 7:30–7:33am |
Find decision makers at Genentech
Tell us what you sell and we’ll find the people at Genentech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction